Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Oklahoma

    Tag: oklahoma

    You Searched For "Oklahoma"
    Oklahoma judge to rule in opioid lawsuit against JnJ

    Oklahoma judge to rule in opioid lawsuit against JnJ

    Medical Dialogues Bureau24 Aug 2019 9:10 AM IST
    Lawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Medical Dialogues Bureau24 Aug 2019 9:00 AM IST
    Allergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
    Oklahoma judge denies motion to end case against drugmaker JnJ

    Oklahoma judge denies motion to end case against drugmaker JnJ

    Medical Dialogues Bureau9 July 2019 9:00 AM IST
    District Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
    Oklahoma judge approves Teva Pharma USD 85 million opioid settlement

    Oklahoma judge approves Teva Pharma USD 85 million opioid settlement

    Medical Dialogues Bureau25 Jun 2019 9:00 AM IST
    U.S: An Oklahoma judge on Monday approved a revised $85 million settlement with Teva Pharmaceutical Industries Ltd (Teva Pharma) resolving claims by...
    Teva Pharma to settle $85 million opioid claims of Oklahoma

    Teva Pharma to settle $85 million opioid claims of Oklahoma

    Medical Dialogues Bureau27 May 2019 9:00 AM IST
    Oklahoma Attorney General Mike Hunter has alleged that JnJ and Teva Pharma, along with OxyContin maker Purdue Pharma LP, carried out deceptive marking...
    New York sues billionaire family behind maker of OxyContin

    New York sues billionaire family behind maker of OxyContin

    Garima30 March 2019 9:00 AM IST
    NEW YORK: New York is suing the billionaire family behind the company that created OxyContin, joining a growing list of state and local governments...
    Purdue Pharma agrees to pay $270 million to settle opioid case

    Purdue Pharma agrees to pay $270 million to settle opioid case

    Medical Dialogues Bureau28 March 2019 9:15 AM IST
    Purdue Pharma introduced OxyContin in the 1990s and marketed it hard to doctors, making tens of billions of dollars from the drug. But the company has...
    Oklahoma Medicaid tests new tactic to curb US drug costs

    Oklahoma Medicaid tests new tactic to curb US drug costs

    Ruby Khatun Khatun25 Aug 2018 9:45 AM IST
    LOS ANGELES: A new front in the battle over the cost of expensive medicines in the United States is opening up in Oklahoma, the first state where the...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok